Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000149

President and CEO sold 495,282 shares at $15.00 ($7,429,230)

  • President and CEO acquired 495,282 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Watts Ryan J. President and CEO 2025-07-09 Option exercise 10b5-1 +455,282 $0.68 $309,592 708,353 D
Watts Ryan J. President and CEO 2025-07-09 Option exercise 10b5-1 +40,000 $5.28 $211,200 748,353 D
Watts Ryan J. President and CEO 2025-07-09 Sale 10b5-1 −495,282 $15.00 $7,429,230 253,071 D
Derivatives
Watts Ryan J. President and CEO 2025-07-09 Option exercise · Stock Option (right to buy) 10b5-1 −455,282 622,809 D
Watts Ryan J. President and CEO 2025-07-09 Option exercise · Stock Option (right to buy) 10b5-1 −40,000 20,369 D
Open-market sales · 495,282 sh · avg $15.00 · $7,429,230
Loading xslF345X05/wk-form4_1752268398.xml…